The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
From each blood sample three metabolomic samples were prepared: whole blood, plasma, and red blood cells (RBCs)
doi: 10.1001/jamapediatrics.2013.4200
Senescent cells: an emerging target for diseases of ageing
Americas gyms are adjusting their strategies as more of their members take weight loss drugs
Weight loss injections are typically recommended for adults over 18